BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T090000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260405T163854
CREATED:20200330T191012Z
LAST-MODIFIED:20200330T191012Z
UID:26511-1587546000-1587553200@scienceinseattle.com
SUMMARY:Webinar: Every Cell Has Its Place - In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes.
URL:https://scienceinseattle.com/event/webinar-every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Every-cell-has-its-place-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T113000
DTSTAMP:20260405T163854
CREATED:20200416T220153Z
LAST-MODIFIED:20200416T220153Z
UID:8929-1587549600-1587555000@scienceinseattle.com
SUMMARY:STAT Digital Event Series: Combating Covid-19
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nSchedule: Please note\, dates and times are subject to change as the story evolves. \nPart 1: Antibody drugs that target the coronavirus. April 8\, 2020 at 1 PM EST \n\nSponsor Introduction: Stephen J. Ubl\, president and chief executive officer\, PhRMA\nGeorge Yancopoulos\, co-founder\, president and chief scientific officer\, Regeneron\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT\n\nYou can watch the recorded conversation with George Yancopoulos here. \nPart 2: Antiviral treatments — what are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT\n\nPart 3: Vaccines — can they come soon enough? May 6\, 2020 at 1PM EST \n\nSponsor Introduction: Clem Lewin\, Ph.D.\, associate vice president of R&D strategy for vaccines\, Sanofi\nTal Zaks\, chief medical officer\, Moderna\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinseattle.com/event/stat-digital-event-series-combating-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/STAT.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T113000
DTSTAMP:20260405T163854
CREATED:20200416T220153Z
LAST-MODIFIED:20200416T220153Z
UID:25562-1587549600-1587555000@scienceinseattle.com
SUMMARY:STAT Digital Event Series: Combating Covid-19
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nSchedule: Please note\, dates and times are subject to change as the story evolves. \nPart 1: Antibody drugs that target the coronavirus. April 8\, 2020 at 1 PM EST \n\nSponsor Introduction: Stephen J. Ubl\, president and chief executive officer\, PhRMA\nGeorge Yancopoulos\, co-founder\, president and chief scientific officer\, Regeneron\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT\n\nYou can watch the recorded conversation with George Yancopoulos here. \nPart 2: Antiviral treatments — what are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT\n\nPart 3: Vaccines — can they come soon enough? May 6\, 2020 at 1PM EST \n\nSponsor Introduction: Clem Lewin\, Ph.D.\, associate vice president of R&D strategy for vaccines\, Sanofi\nTal Zaks\, chief medical officer\, Moderna\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinseattle.com/event/stat-digital-event-series-combating-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/STAT.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T113000
DTSTAMP:20260405T163854
CREATED:20200416T220153Z
LAST-MODIFIED:20200416T220153Z
UID:26527-1587549600-1587555000@scienceinseattle.com
SUMMARY:STAT Digital Event Series: Combating Covid-19
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nSchedule: Please note\, dates and times are subject to change as the story evolves. \nPart 1: Antibody drugs that target the coronavirus. April 8\, 2020 at 1 PM EST \n\nSponsor Introduction: Stephen J. Ubl\, president and chief executive officer\, PhRMA\nGeorge Yancopoulos\, co-founder\, president and chief scientific officer\, Regeneron\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT\n\nYou can watch the recorded conversation with George Yancopoulos here. \nPart 2: Antiviral treatments — what are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT\n\nPart 3: Vaccines — can they come soon enough? May 6\, 2020 at 1PM EST \n\nSponsor Introduction: Clem Lewin\, Ph.D.\, associate vice president of R&D strategy for vaccines\, Sanofi\nTal Zaks\, chief medical officer\, Moderna\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinseattle.com/event/stat-digital-event-series-combating-covid-19-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/STAT.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T160000
DTEND;TZID=America/Vancouver:20200422T170000
DTSTAMP:20260405T163854
CREATED:20200414T225636Z
LAST-MODIFIED:20200414T225636Z
UID:8905-1587571200-1587574800@scienceinseattle.com
SUMMARY:Science Matters: Curiosity Drives Discovery
DESCRIPTION:COVID-19 has propelled scientists into the limelight as the world awaits the availability of new tests\, drugs\, and vaccines to help fight the pandemic. \nWho are these men and women of science? What drives them to pursue their work? How do today’s scientific discoveries shape tomorrow’s breakthroughs. \nJoin us for a conversation with PNRI scientist David Galas\, PhD. Some of his notable achievements include overseeing the Human Genome Project\, discovering a technology that was recently used by Abbott Laboratories to develop a rapid test for COVID-19\, and developing a groundbreaking mathematical approach to unraveling the complexities of biology. \nDr. Galas will share stories about his life and career as a scientist\, and his thoughts on the role of science and technology in today’s world.
URL:https://scienceinseattle.com/event/science-matters-curiosity-drives-discovery-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/PNRI.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T160000
DTEND;TZID=America/Vancouver:20200422T170000
DTSTAMP:20260405T163854
CREATED:20200414T225636Z
LAST-MODIFIED:20200414T225636Z
UID:25560-1587571200-1587574800@scienceinseattle.com
SUMMARY:Science Matters: Curiosity Drives Discovery
DESCRIPTION:COVID-19 has propelled scientists into the limelight as the world awaits the availability of new tests\, drugs\, and vaccines to help fight the pandemic. \nWho are these men and women of science? What drives them to pursue their work? How do today’s scientific discoveries shape tomorrow’s breakthroughs. \nJoin us for a conversation with PNRI scientist David Galas\, PhD. Some of his notable achievements include overseeing the Human Genome Project\, discovering a technology that was recently used by Abbott Laboratories to develop a rapid test for COVID-19\, and developing a groundbreaking mathematical approach to unraveling the complexities of biology. \nDr. Galas will share stories about his life and career as a scientist\, and his thoughts on the role of science and technology in today’s world.
URL:https://scienceinseattle.com/event/science-matters-curiosity-drives-discovery-2-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/PNRI.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T160000
DTEND;TZID=America/Vancouver:20200422T170000
DTSTAMP:20260405T163854
CREATED:20200414T225636Z
LAST-MODIFIED:20200414T225636Z
UID:26525-1587571200-1587574800@scienceinseattle.com
SUMMARY:Science Matters: Curiosity Drives Discovery
DESCRIPTION:COVID-19 has propelled scientists into the limelight as the world awaits the availability of new tests\, drugs\, and vaccines to help fight the pandemic. \nWho are these men and women of science? What drives them to pursue their work? How do today’s scientific discoveries shape tomorrow’s breakthroughs. \nJoin us for a conversation with PNRI scientist David Galas\, PhD. Some of his notable achievements include overseeing the Human Genome Project\, discovering a technology that was recently used by Abbott Laboratories to develop a rapid test for COVID-19\, and developing a groundbreaking mathematical approach to unraveling the complexities of biology. \nDr. Galas will share stories about his life and career as a scientist\, and his thoughts on the role of science and technology in today’s world.
URL:https://scienceinseattle.com/event/science-matters-curiosity-drives-discovery-2-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/PNRI.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200423T150000
DTEND;TZID=America/Vancouver:20200423T160000
DTSTAMP:20260405T163854
CREATED:20200413T175655Z
LAST-MODIFIED:20200413T175655Z
UID:8844-1587654000-1587657600@scienceinseattle.com
SUMMARY:Responding to COVID-19:  A Ground-Zero Perspective from Washington’s Life Science Community
DESCRIPTION:Life Science Washington and the University of Washington have teamed up to share stories and perspectives from scientists\, researchers\, and policymakers about the COVID-19 response. \n  \nThis webinar\, moderated by Luke Timmerman\, will explore how Washington institutions are partnering with public health officials to lower our regional pandemic curve. The Seattle region was the epicenter of the COVID-19 virus and therefore first to address the crisis both through our life science research institutions and public policy. \nLuke Timmerman is an award-winning journalist who has been covering biotechnology since 2001. Before founding Timmerman Report in 2015\, Luke wrote about the industry for a regional newspaper (The Seattle Times)\, a global financial publication (Bloomberg News)\, and an online startup (Xconomy). Luke’s first book\, “Hood: Trailblazer of the Genomics Age” was called a “must-read” by Forbes\, and named one of the “100 Best Indie Books of 2017” by Kirkus Reviews. \nLuke was named one of the 100 Most Influential People in Biotechnology by Scientific American in 2015. He has won a number of journalism prizes\, including the Scripps Howard National Journalism Award\, the Association of Health Care Journalists Award\, and the Society of American Business Editors and Writers (SABEW) award. Luke received his bachelor’s degree in journalism from the University of Wisconsin-Madison in 1997. For the 2005-2006 academic year\, he was awarded a Knight Science Journalism Fellow at MIT.
URL:https://scienceinseattle.com/event/responding-to-covid-19-a-ground-zero-perspective-from-washingtons-life-science-community/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200423T150000
DTEND;TZID=America/Vancouver:20200423T160000
DTSTAMP:20260405T163854
CREATED:20200413T175655Z
LAST-MODIFIED:20200413T175655Z
UID:25558-1587654000-1587657600@scienceinseattle.com
SUMMARY:Responding to COVID-19:  A Ground-Zero Perspective from Washington’s Life Science Community
DESCRIPTION:Life Science Washington and the University of Washington have teamed up to share stories and perspectives from scientists\, researchers\, and policymakers about the COVID-19 response. \n  \nThis webinar\, moderated by Luke Timmerman\, will explore how Washington institutions are partnering with public health officials to lower our regional pandemic curve. The Seattle region was the epicenter of the COVID-19 virus and therefore first to address the crisis both through our life science research institutions and public policy. \nLuke Timmerman is an award-winning journalist who has been covering biotechnology since 2001. Before founding Timmerman Report in 2015\, Luke wrote about the industry for a regional newspaper (The Seattle Times)\, a global financial publication (Bloomberg News)\, and an online startup (Xconomy). Luke’s first book\, “Hood: Trailblazer of the Genomics Age” was called a “must-read” by Forbes\, and named one of the “100 Best Indie Books of 2017” by Kirkus Reviews. \nLuke was named one of the 100 Most Influential People in Biotechnology by Scientific American in 2015. He has won a number of journalism prizes\, including the Scripps Howard National Journalism Award\, the Association of Health Care Journalists Award\, and the Society of American Business Editors and Writers (SABEW) award. Luke received his bachelor’s degree in journalism from the University of Wisconsin-Madison in 1997. For the 2005-2006 academic year\, he was awarded a Knight Science Journalism Fellow at MIT.
URL:https://scienceinseattle.com/event/responding-to-covid-19-a-ground-zero-perspective-from-washingtons-life-science-community-2/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200423T150000
DTEND;TZID=America/Vancouver:20200423T160000
DTSTAMP:20260405T163854
CREATED:20200413T175655Z
LAST-MODIFIED:20200413T175655Z
UID:26523-1587654000-1587657600@scienceinseattle.com
SUMMARY:Responding to COVID-19:  A Ground-Zero Perspective from Washington’s Life Science Community
DESCRIPTION:Life Science Washington and the University of Washington have teamed up to share stories and perspectives from scientists\, researchers\, and policymakers about the COVID-19 response. \n  \nThis webinar\, moderated by Luke Timmerman\, will explore how Washington institutions are partnering with public health officials to lower our regional pandemic curve. The Seattle region was the epicenter of the COVID-19 virus and therefore first to address the crisis both through our life science research institutions and public policy. \nLuke Timmerman is an award-winning journalist who has been covering biotechnology since 2001. Before founding Timmerman Report in 2015\, Luke wrote about the industry for a regional newspaper (The Seattle Times)\, a global financial publication (Bloomberg News)\, and an online startup (Xconomy). Luke’s first book\, “Hood: Trailblazer of the Genomics Age” was called a “must-read” by Forbes\, and named one of the “100 Best Indie Books of 2017” by Kirkus Reviews. \nLuke was named one of the 100 Most Influential People in Biotechnology by Scientific American in 2015. He has won a number of journalism prizes\, including the Scripps Howard National Journalism Award\, the Association of Health Care Journalists Award\, and the Society of American Business Editors and Writers (SABEW) award. Luke received his bachelor’s degree in journalism from the University of Wisconsin-Madison in 1997. For the 2005-2006 academic year\, he was awarded a Knight Science Journalism Fellow at MIT.
URL:https://scienceinseattle.com/event/responding-to-covid-19-a-ground-zero-perspective-from-washingtons-life-science-community-3/
LOCATION:Online
ORGANIZER;CN="Life Science Washington":MAILTO:kaitlyn@lifesciencewa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200427T080000
DTEND;TZID=America/Vancouver:20200427T090000
DTSTAMP:20260405T163854
CREATED:20200423T225335Z
LAST-MODIFIED:20200423T225335Z
UID:8996-1587974400-1587978000@scienceinseattle.com
SUMMARY:STAT Video Chat: A Conversation on the Coronavirus with Rich Besser
DESCRIPTION:A STAT Video chat with former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation\, Rich Besser\n\n\n\n\n\n\nAbout this Event\n\n\nABOUT THE CHAT \nRich Besser is a leading public health expert and the former acting director of the Centers for Disease Control and Prevention. He has drawn on his experience to offer both criticism and commendation of global response efforts to the pandemic\, and has emphasized the health inequities being brought to light as a result. Join STAT’s senior infectious diseases and global health reporter\, Helen Branswell\, for a live video chat with Dr. Besser\, who is now president and CEO of the Robert Wood Johnson Foundation\, at 11 a.m. EDT on Monday\, April 27. They’ll be talking about the current state of the pandemic\, how communities across the country are being impacted\, and how we can work together in response. \nQuestions for Dr. Besser? Submit a question in advance when you register. \nHOW IT WORKS \nWe’ll be hosting this live chat as a Zoom webinar. Register here to sign up for the chat\, and we’ll reach out to you at the email address provided with a link to access the chat. A live stream link will also be provided. Please feel free to join there if the Zoom room is full.
URL:https://scienceinseattle.com/event/stat-video-chat-a-conversation-on-the-coronavirus-with-rich-besser/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/STAT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200427T080000
DTEND;TZID=America/Vancouver:20200427T090000
DTSTAMP:20260405T163854
CREATED:20200423T225335Z
LAST-MODIFIED:20200423T225335Z
UID:25566-1587974400-1587978000@scienceinseattle.com
SUMMARY:STAT Video Chat: A Conversation on the Coronavirus with Rich Besser
DESCRIPTION:A STAT Video chat with former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation\, Rich Besser\n\n\n\n\n\n\nAbout this Event\n\n\nABOUT THE CHAT \nRich Besser is a leading public health expert and the former acting director of the Centers for Disease Control and Prevention. He has drawn on his experience to offer both criticism and commendation of global response efforts to the pandemic\, and has emphasized the health inequities being brought to light as a result. Join STAT’s senior infectious diseases and global health reporter\, Helen Branswell\, for a live video chat with Dr. Besser\, who is now president and CEO of the Robert Wood Johnson Foundation\, at 11 a.m. EDT on Monday\, April 27. They’ll be talking about the current state of the pandemic\, how communities across the country are being impacted\, and how we can work together in response. \nQuestions for Dr. Besser? Submit a question in advance when you register. \nHOW IT WORKS \nWe’ll be hosting this live chat as a Zoom webinar. Register here to sign up for the chat\, and we’ll reach out to you at the email address provided with a link to access the chat. A live stream link will also be provided. Please feel free to join there if the Zoom room is full.
URL:https://scienceinseattle.com/event/stat-video-chat-a-conversation-on-the-coronavirus-with-rich-besser-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/STAT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200427T080000
DTEND;TZID=America/Vancouver:20200427T090000
DTSTAMP:20260405T163854
CREATED:20200423T225335Z
LAST-MODIFIED:20200423T225335Z
UID:26531-1587974400-1587978000@scienceinseattle.com
SUMMARY:STAT Video Chat: A Conversation on the Coronavirus with Rich Besser
DESCRIPTION:A STAT Video chat with former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation\, Rich Besser\n\n\n\n\n\n\nAbout this Event\n\n\nABOUT THE CHAT \nRich Besser is a leading public health expert and the former acting director of the Centers for Disease Control and Prevention. He has drawn on his experience to offer both criticism and commendation of global response efforts to the pandemic\, and has emphasized the health inequities being brought to light as a result. Join STAT’s senior infectious diseases and global health reporter\, Helen Branswell\, for a live video chat with Dr. Besser\, who is now president and CEO of the Robert Wood Johnson Foundation\, at 11 a.m. EDT on Monday\, April 27. They’ll be talking about the current state of the pandemic\, how communities across the country are being impacted\, and how we can work together in response. \nQuestions for Dr. Besser? Submit a question in advance when you register. \nHOW IT WORKS \nWe’ll be hosting this live chat as a Zoom webinar. Register here to sign up for the chat\, and we’ll reach out to you at the email address provided with a link to access the chat. A live stream link will also be provided. Please feel free to join there if the Zoom room is full.
URL:https://scienceinseattle.com/event/stat-video-chat-a-conversation-on-the-coronavirus-with-rich-besser-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/STAT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200429T090000
DTEND;TZID=America/Vancouver:20200429T110000
DTSTAMP:20260405T163854
CREATED:20200427T204134Z
LAST-MODIFIED:20200427T204134Z
UID:9012-1588150800-1588158000@scienceinseattle.com
SUMMARY:Webinar: Mechanisms of Cross-Talk between Histone Ubiquitination and Methylation
DESCRIPTION:Cynthia Wolberger: Mechanisms of cross-talk between histone ubiquitination and methylation. Seminar of the #FragileNucleosome online discussion group
URL:https://scienceinseattle.com/event/webinar-mechanisms-of-cross-talk-between-histone-ubiquitination-and-methylation/
LOCATION:WA
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/webinar-2636737_1920.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200429T090000
DTEND;TZID=America/Vancouver:20200429T110000
DTSTAMP:20260405T163854
CREATED:20200427T204134Z
LAST-MODIFIED:20200427T204134Z
UID:25568-1588150800-1588158000@scienceinseattle.com
SUMMARY:Webinar: Mechanisms of Cross-Talk between Histone Ubiquitination and Methylation
DESCRIPTION:Cynthia Wolberger: Mechanisms of cross-talk between histone ubiquitination and methylation. Seminar of the #FragileNucleosome online discussion group
URL:https://scienceinseattle.com/event/webinar-mechanisms-of-cross-talk-between-histone-ubiquitination-and-methylation-2/
LOCATION:WA
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/webinar-2636737_1920.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200429T090000
DTEND;TZID=America/Vancouver:20200429T110000
DTSTAMP:20260405T163854
CREATED:20200427T204134Z
LAST-MODIFIED:20200427T204134Z
UID:26533-1588150800-1588158000@scienceinseattle.com
SUMMARY:Webinar: Mechanisms of Cross-Talk between Histone Ubiquitination and Methylation
DESCRIPTION:Cynthia Wolberger: Mechanisms of cross-talk between histone ubiquitination and methylation. Seminar of the #FragileNucleosome online discussion group
URL:https://scienceinseattle.com/event/webinar-mechanisms-of-cross-talk-between-histone-ubiquitination-and-methylation-3/
LOCATION:WA
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/04/webinar-2636737_1920.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200430T120000
DTEND;TZID=America/Vancouver:20200430T130000
DTSTAMP:20260405T163854
CREATED:20200424T215215Z
LAST-MODIFIED:20200424T215215Z
UID:9000-1588248000-1588251600@scienceinseattle.com
SUMMARY:Fred Hutch Donor Town Hall
DESCRIPTION:Join us for a virtual town hall to meet our new president\, hear from Hutch experts\, and ask your questions about COVID-19 and cancer research. Please note\, this event is scheduled for noon Pacific Daylight Time (PDT). If you are joining from a different time zone\, please adjust accordingly.
URL:https://scienceinseattle.com/event/fred-hutch-donor-town-hall/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2019/01/Fred-Hutch.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200430T120000
DTEND;TZID=America/Vancouver:20200430T130000
DTSTAMP:20260405T163854
CREATED:20200424T215215Z
LAST-MODIFIED:20200424T215215Z
UID:25567-1588248000-1588251600@scienceinseattle.com
SUMMARY:Fred Hutch Donor Town Hall
DESCRIPTION:Join us for a virtual town hall to meet our new president\, hear from Hutch experts\, and ask your questions about COVID-19 and cancer research. Please note\, this event is scheduled for noon Pacific Daylight Time (PDT). If you are joining from a different time zone\, please adjust accordingly.
URL:https://scienceinseattle.com/event/fred-hutch-donor-town-hall-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2019/01/Fred-Hutch.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200430T120000
DTEND;TZID=America/Vancouver:20200430T130000
DTSTAMP:20260405T163854
CREATED:20200424T215215Z
LAST-MODIFIED:20200424T215215Z
UID:26532-1588248000-1588251600@scienceinseattle.com
SUMMARY:Fred Hutch Donor Town Hall
DESCRIPTION:Join us for a virtual town hall to meet our new president\, hear from Hutch experts\, and ask your questions about COVID-19 and cancer research. Please note\, this event is scheduled for noon Pacific Daylight Time (PDT). If you are joining from a different time zone\, please adjust accordingly.
URL:https://scienceinseattle.com/event/fred-hutch-donor-town-hall-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2019/01/Fred-Hutch.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200501T110000
DTEND;TZID=America/Vancouver:20200501T120000
DTSTAMP:20260405T163854
CREATED:20200421T193353Z
LAST-MODIFIED:20200421T193408Z
UID:8958-1588330800-1588334400@scienceinseattle.com
SUMMARY:Pre-/Post-Publication Peer Review
DESCRIPTION:Pre-/post-publication peer review: You do a study\, you write up the paper\, and then you publish it. That’s it\, right? Not so fast: peer review has always been a recurring step in the scientific process\, but methods to do so are even more widespread than ever. We will talk about benefits and challenges of using preprint sites like bioRxiv\, and the wide world of peer-reviewed feedback after publishing your manuscript.
URL:https://scienceinseattle.com/event/pre-post-publication-peer-review/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200501T110000
DTEND;TZID=America/Vancouver:20200501T120000
DTSTAMP:20260405T163854
CREATED:20200421T193353Z
LAST-MODIFIED:20200421T193353Z
UID:25564-1588330800-1588334400@scienceinseattle.com
SUMMARY:Pre-/Post-Publication Peer Review
DESCRIPTION:Pre-/post-publication peer review: You do a study\, you write up the paper\, and then you publish it. That’s it\, right? Not so fast: peer review has always been a recurring step in the scientific process\, but methods to do so are even more widespread than ever. We will talk about benefits and challenges of using preprint sites like bioRxiv\, and the wide world of peer-reviewed feedback after publishing your manuscript.
URL:https://scienceinseattle.com/event/pre-post-publication-peer-review-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200501T110000
DTEND;TZID=America/Vancouver:20200501T120000
DTSTAMP:20260405T163854
CREATED:20200421T193353Z
LAST-MODIFIED:20200421T193353Z
UID:26529-1588330800-1588334400@scienceinseattle.com
SUMMARY:Pre-/Post-Publication Peer Review
DESCRIPTION:Pre-/post-publication peer review: You do a study\, you write up the paper\, and then you publish it. That’s it\, right? Not so fast: peer review has always been a recurring step in the scientific process\, but methods to do so are even more widespread than ever. We will talk about benefits and challenges of using preprint sites like bioRxiv\, and the wide world of peer-reviewed feedback after publishing your manuscript.
URL:https://scienceinseattle.com/event/pre-post-publication-peer-review-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200507T160000
DTEND;TZID=America/Vancouver:20200507T163000
DTSTAMP:20260405T163854
CREATED:20200504T223523Z
LAST-MODIFIED:20200504T223523Z
UID:9085-1588867200-1588869000@scienceinseattle.com
SUMMARY:CFAR Seminar
DESCRIPTION:New Faces Speaker: Dan Reeves\, PhD \nTitle: HIV reservoir clones\, how they got there\, why they stay \nAffiliation: Fred Hutchinson Cancer Research Center \nDr. Dan Reeves is an Associate in VID at the Fred Hutchinson Cancer Research Center (Fred Hutch) in Seattle. He received a PhD in physics at Dartmouth College and was trained in infectious diseases by Dr Josh Schiffer. His work now focuses on viral and immune system modeling\, including evolutionary dynamics and is particularly directed at developing rational interventions for HIV cure.
URL:https://scienceinseattle.com/event/cfar-seminar/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200507T160000
DTEND;TZID=America/Vancouver:20200507T163000
DTSTAMP:20260405T163854
CREATED:20200504T223523Z
LAST-MODIFIED:20200504T223523Z
UID:25570-1588867200-1588869000@scienceinseattle.com
SUMMARY:CFAR Seminar
DESCRIPTION:New Faces Speaker: Dan Reeves\, PhD \nTitle: HIV reservoir clones\, how they got there\, why they stay \nAffiliation: Fred Hutchinson Cancer Research Center \nDr. Dan Reeves is an Associate in VID at the Fred Hutchinson Cancer Research Center (Fred Hutch) in Seattle. He received a PhD in physics at Dartmouth College and was trained in infectious diseases by Dr Josh Schiffer. His work now focuses on viral and immune system modeling\, including evolutionary dynamics and is particularly directed at developing rational interventions for HIV cure.
URL:https://scienceinseattle.com/event/cfar-seminar-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200507T160000
DTEND;TZID=America/Vancouver:20200507T163000
DTSTAMP:20260405T163854
CREATED:20200504T223523Z
LAST-MODIFIED:20200504T223523Z
UID:26535-1588867200-1588869000@scienceinseattle.com
SUMMARY:CFAR Seminar
DESCRIPTION:New Faces Speaker: Dan Reeves\, PhD \nTitle: HIV reservoir clones\, how they got there\, why they stay \nAffiliation: Fred Hutchinson Cancer Research Center \nDr. Dan Reeves is an Associate in VID at the Fred Hutchinson Cancer Research Center (Fred Hutch) in Seattle. He received a PhD in physics at Dartmouth College and was trained in infectious diseases by Dr Josh Schiffer. His work now focuses on viral and immune system modeling\, including evolutionary dynamics and is particularly directed at developing rational interventions for HIV cure.
URL:https://scienceinseattle.com/event/cfar-seminar-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200508T050000
DTEND;TZID=America/Vancouver:20200508T130000
DTSTAMP:20260405T163854
CREATED:20200421T193644Z
LAST-MODIFIED:20200421T193644Z
UID:8961-1588914000-1588942800@scienceinseattle.com
SUMMARY:NIH Online Career Symposium
DESCRIPTION:This year we will be moving the NIH Career to an online event. Look for online panels\, taped interviews\, and Twitter chats to get the same information to plan your career path. We will be posting more information soon! (updated 3-20-19) \nThe NIH Career Symposium highlights the diversity of career choices available to your generation of biomedical researchers.  Whether you are a new graduate student\, postdoc\, or clinical fellow just beginning to consider career options or a senior student/fellow ready to look for a job\, the NIH Career Symposium is for you. \nWe invite any postdoc\, clinical fellow or PhD-level graduate student to join us\, regardless if you are part of the NIH intramural program or not. This event is free to attend (participants are responsible for their own travel expenses) \nWondering what the Career Symposium is all about?  Check out past events here.
URL:https://scienceinseattle.com/event/nih-online-career-symposium/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200508T050000
DTEND;TZID=America/Vancouver:20200508T130000
DTSTAMP:20260405T163854
CREATED:20200421T193644Z
LAST-MODIFIED:20200421T193644Z
UID:25565-1588914000-1588942800@scienceinseattle.com
SUMMARY:NIH Online Career Symposium
DESCRIPTION:This year we will be moving the NIH Career to an online event. Look for online panels\, taped interviews\, and Twitter chats to get the same information to plan your career path. We will be posting more information soon! (updated 3-20-19) \nThe NIH Career Symposium highlights the diversity of career choices available to your generation of biomedical researchers.  Whether you are a new graduate student\, postdoc\, or clinical fellow just beginning to consider career options or a senior student/fellow ready to look for a job\, the NIH Career Symposium is for you. \nWe invite any postdoc\, clinical fellow or PhD-level graduate student to join us\, regardless if you are part of the NIH intramural program or not. This event is free to attend (participants are responsible for their own travel expenses) \nWondering what the Career Symposium is all about?  Check out past events here.
URL:https://scienceinseattle.com/event/nih-online-career-symposium-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200508T050000
DTEND;TZID=America/Vancouver:20200508T130000
DTSTAMP:20260405T163854
CREATED:20200421T193644Z
LAST-MODIFIED:20200421T193644Z
UID:26530-1588914000-1588942800@scienceinseattle.com
SUMMARY:NIH Online Career Symposium
DESCRIPTION:This year we will be moving the NIH Career to an online event. Look for online panels\, taped interviews\, and Twitter chats to get the same information to plan your career path. We will be posting more information soon! (updated 3-20-19) \nThe NIH Career Symposium highlights the diversity of career choices available to your generation of biomedical researchers.  Whether you are a new graduate student\, postdoc\, or clinical fellow just beginning to consider career options or a senior student/fellow ready to look for a job\, the NIH Career Symposium is for you. \nWe invite any postdoc\, clinical fellow or PhD-level graduate student to join us\, regardless if you are part of the NIH intramural program or not. This event is free to attend (participants are responsible for their own travel expenses) \nWondering what the Career Symposium is all about?  Check out past events here.
URL:https://scienceinseattle.com/event/nih-online-career-symposium-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260405T163854
CREATED:20200511T143500Z
LAST-MODIFIED:20200511T143500Z
UID:9140-1589371200-1589374800@scienceinseattle.com
SUMMARY:Return to Workplace – Insights from Life Science CEOs Across the US
DESCRIPTION:Join Biocom\, MassBio and Thermo Fisher Scientific as we convene industry CEOs to share their insights on COVID-19 testing\, the race for a vaccine\, as well as how these leaders are preparing for the return of their workforce. In this ever changing landscape guidance’s and best practices are changing every day. Join us on May 13th as CEO’s from East and West provide you with the most updated information. \nPanel Discussion \nModerator: \nPaul Jorjorian\, Vice President/General Manager\, Biologics\, Patheon \nPanelists: \nBassil Dahiyat\, President and Chief Executive Officer\, Xencor \nJohn Maraganore\, Chief Executive Officer\, Alnylam \nDawn Verdugo\, Co-Founder and Chief Executive Officer\, YuFlu
URL:https://scienceinseattle.com/event/return-to-workplace-insights-from-life-science-ceos-across-the-us/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/05/biocom.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200513T120000
DTEND;TZID=America/Vancouver:20200513T130000
DTSTAMP:20260405T163854
CREATED:20200511T143500Z
LAST-MODIFIED:20200511T143500Z
UID:25575-1589371200-1589374800@scienceinseattle.com
SUMMARY:Return to Workplace – Insights from Life Science CEOs Across the US
DESCRIPTION:Join Biocom\, MassBio and Thermo Fisher Scientific as we convene industry CEOs to share their insights on COVID-19 testing\, the race for a vaccine\, as well as how these leaders are preparing for the return of their workforce. In this ever changing landscape guidance’s and best practices are changing every day. Join us on May 13th as CEO’s from East and West provide you with the most updated information. \nPanel Discussion \nModerator: \nPaul Jorjorian\, Vice President/General Manager\, Biologics\, Patheon \nPanelists: \nBassil Dahiyat\, President and Chief Executive Officer\, Xencor \nJohn Maraganore\, Chief Executive Officer\, Alnylam \nDawn Verdugo\, Co-Founder and Chief Executive Officer\, YuFlu
URL:https://scienceinseattle.com/event/return-to-workplace-insights-from-life-science-ceos-across-the-us-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/05/biocom.jpg
END:VEVENT
END:VCALENDAR